Unveiling Tb Med 577: A Novel Breakthrough In Tuberculosis Treatment
TB Med 577, an anti-tuberculosis agent, selectively targets Mycobacterium species by inhibiting bacterial RNA polymerase, thus halting bacterial replication. Its spectrum includes Mycobacterium tuberculosis strains,… Read More »Unveiling Tb Med 577: A Novel Breakthrough In Tuberculosis Treatment